Close

Anti-Human PDCD1 Therapeutic Antibody (TAB-H55)

DESCRIPTION CATALOG # SIZE PRICE
Anti-Human PDCD1 Therapeutic Antibody TAB-H55 1mg Please Inquiry

PRODUCT INFORMATION

  • Product Overview
  • Recombinant Humanized (from mouse) antibody to Human PDCD1. It is a drug that targets the programmed cell death 1 (PD-1) receptor. The drug is intended for use in treating metastatic melanoma.
  • Type
  • IgG4 - kappa
  • Species Reactivity
  • Human
  • Expression Host
  • CHO
  • Applications
  • Suitable for use in Neut, ELISA, IF, IP, FuncS, FC, WB and most other immunological methods.
  • CAS
  • 1374853-91-4
  • Specificity
  • PDCD1(programmed cell death 1, PD-1, PD1, CD279) [Homo sapiens]
  • Protein Construction
  • humanized mouse monoclonal [228- L- proline(H10- S>P)]γ4 heavy chain (134-218') – disulfide with humanized mouse monoclonal κ light chain dimer (226-226':229-229')
  • Purity
  • >95%, by SDS-PAGE with silver staining, under reducing conditions.

BACKGROUND

  • Antigen Description
  • Programmed cell death protein 1, also known as PD-1 and CD279 (cluster of differentiation 279), is a protein that in humans is encoded by the PDCD1 gene. PD-1 is a cell surface receptor that belongs to the immunoglobulin superfamily and is expressed on T cells and pro-B cells. PD-1 binds two ligands, PD-L1 and PD-L2.
  • Function
  • protein binding; protein tyrosine phosphatase activity; signal transducer activity;
  • Synonyms
  • PDCD1; programmed cell death 1; programmed cell death protein 1; CD279; PD1; protein PD-1; PD-1; SLEB2; hPD-1; hPD-l;

Related Products

Online Inquiry

Verification code
Click image to refresh the verification code.

CONTACT US

45-1 Ramsey Road, Shirley, NY 11967, USA
Call us at:
USA: 1-631-381-2994
Europe: 44-207-097-1828
Fax: 1-631-207-8356
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us